Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) was the target of a significant growth in short interest in January. As of January 15th, there was short interest totalling 63,900 shares, a growth of 428.1% from the December 31st total of 12,100 shares. Based on an average daily trading volume, of 124,300 shares, the days-to-cover ratio is presently 0.5 days.

Fresenius SE & Co. KGaA Stock Performance

Shares of Fresenius SE & Co. KGaA stock traded up $0.02 on Tuesday, reaching $9.76. The company had a trading volume of 256,515 shares, compared to its average volume of 89,901. Fresenius SE & Co. KGaA has a 52-week low of $6.57 and a 52-week high of $9.84. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.36 and a quick ratio of 1.05. The firm’s 50 day moving average price is $8.95 and its two-hundred day moving average price is $9.00.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.19 EPS for the quarter. The business had revenue of $5.90 billion during the quarter. As a group, sell-side analysts forecast that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Citigroup raised shares of Fresenius SE & Co. KGaA to a “strong-buy” rating in a research note on Friday, October 25th.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.